WASHINGTON – Former Advamed CEO Stephen Ubl discussed the need to create a sound regulatory and reimbursement environment for personalized medications in his new role as the head of PhRMA, the main trade group representing the pharmaceutical industry. The May 25 keynote address occurred in downtown Washington at an annual conference sponsored by the Personalized Medicine Coalition. Read More